Skip to main content
. 2017 Feb 15;27(1):114–121. doi: 10.11613/BM.2017.015

Table 2. Acceptable performance for each platform of three panels in 2015.

Analyte (units) Platform Number of panels reported effective results Number of laboratories with acceptable performance Acceptable performance (%)*
AFP (μg/L) Beckman 491 488 99.39
Roche 141 140 99.29
DPC 66 66 100.00
AFP (KIU/L) PerkinElmer 588 586 99.66
Fenghua 178 177 99.44
Darui 59 58 98.31
t-hCG (IU/L) DPC 104 100 96.15
Beckman 17 17 100.00
β-hCG (IU/L) Beckman 466 463 99.36
Roche 121 119 98.35
Abbott 26 26 100.00
uE3 (nmol/L) Beckman 497 462 92.96
PerkinElmer 428 425 99.30
DPC 97 95 97.94
free-β-hCG (μg/L) PerkinElmer 589 587 99.66
Fenghua 178 177 99.44
Darui 59 58 98.31
AFP - alpha fetoprotein; t-hCG - total human chorionic gonadotropin; β-hCG - β-human chorionic gonadotropin; uE3 - unconjugated estriol; free-β-hCG - free β-human chorionic gonadotropin.
*The acceptable performance (%) of each platform was defined as the total number of laboratories with acceptable performance of this platform in three panels divided by the total number of laboratories. Acceptable performance was attributed to scores ≥ 80. Acceptable result fell in the range of ± 30% or 5 μg/L (whichever was larger) of the assigned value, ± 30% for hCG, β-hCG, uE3, and free-β-hCG.